GENEPRED is a startup based in Unknown. Brouky records 1 investor associated with the company.
Genepredict lance Melapred Access, l\'examen clinico-génétique de stratification du risque de mélanome. Validé sur 5 200 individus.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.